| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
93,489 |
48,955 |
$6.41M |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
82,595 |
45,402 |
$1.68M |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
63,822 |
35,261 |
$1.40M |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
35,462 |
27,103 |
$1.19M |
| 86769 |
|
1,718 |
1,065 |
$65K |
| 84443 |
Thyroid stimulating hormone (TSH) |
863 |
760 |
$13K |
| 80053 |
Comprehensive metabolic panel |
1,359 |
1,222 |
$13K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,557 |
1,392 |
$8K |
| 80061 |
Lipid panel |
1,396 |
1,187 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,116 |
948 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
51 |
51 |
$2K |
| 81003 |
|
899 |
675 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
55 |
52 |
$370.68 |
| 82607 |
|
12 |
12 |
$123.60 |
| 84480 |
|
12 |
12 |
$92.87 |
| 83735 |
|
12 |
12 |
$58.07 |
| 36415 |
Collection of venous blood by venipuncture |
37 |
31 |
$12.30 |